Company Filing History:
Years Active: 2022
Title: Honnappa Srinivas: Innovator in Antibody Development
Introduction
Honnappa Srinivas is a notable inventor based in Brugg, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins.
Latest Patents
Honnappa holds a patent for TREM2 stabilizing antibodies. This invention provides antibodies that bind to and stabilize the human Triggering Receptor Expressed on Myeloid cells 2 (TREM2) protein, along with methods for utilizing these antibodies in various applications.
Career Highlights
Honnappa is currently employed at Novartis AG, a leading global healthcare company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Some of Honnappa's coworkers include Verena Brand and Dominik Feuerbach. Their collaborative efforts enhance the research and development processes within their team.
Conclusion
Honnappa Srinivas is a distinguished inventor whose work in antibody development is paving the way for new therapeutic approaches. His contributions to the field are invaluable and continue to impact the healthcare industry positively.